US2003206881A1PendingUtilityA1
Phospholipidic composition as well as the use thereof
Priority: May 31, 2001Filed: May 31, 2001Published: Nov 6, 2003
Est. expiryMay 31, 2021(expired)· nominal 20-yr term from priority
A23J 7/00
27
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A phospholipidic composition with an L-α-glycerophosphatidyl-choline concentration of at least 10% by weight is described, where said composition is granular also contains, in addition to L-α-glycerophosphatidylcholine, at least one granulation aid selected from the group consisting of a monophosphate, diphosphate or triphosphate of an alkali metal or an alkaline earth metal or a mixture thereof.
Claims
exact text as granted — not AI-modified1 . A phospholipidic composition with a concentration of L-α-glycerophosphatidylcholine of at least 10% by weight, characterized in that the composition consists of granules and, in addition to containing L-α-glycerophosphatidylcholine, the composition also contains at least one granulation aid selected from the group consisting of a monophosphate, diphosphate or triphosphate of an alkali metal or an alkaline earth metal or a mixture thereof
2 . The phospholipidic composition according to claim 1 , characterized in that the composition contains the granulation aid in a concentration between 2-% by weight and 50% by weight.
3 . The phospholipidic composition according to one of the preceding claims, characterized in that the composition contains the granulation aid in a concentration between 10% by weight and 30% by weight.
4 . The phospholipidic composition according to one of the preceding claims, characterized in that the granules have a particle size between 0.063 mm and 5 mm.
5 . The phospholipidic composition according to one of the preceding claims, characterized in that cellulose and/or silicon dioxide is also present in the composition.
6 . The phospholipidic composition according to claim 5 , characterized in that the cellulose concentration in the composition is between 0.5% by weight and 30 by weight.
7 . The phospholipidic composition according to claim 6 , characterized in that the cellulose concentration in the composition is between 5% by weight and 20% by weight.
8 . The phospholipidic composition according to one of claims 5 till 7 , characterized in that the cellulose has an average particle size between 60 μm and 150 μm, preferably between 90 μm and 120 μm.
9 . The phospholipidic composition according to one of claims 5 till 8 , characterized in that the silicon dioxide concentration in the composition varies between 0.5% by weight and 3% by weight, preferably between 1% by weight and 2% by weight.
10 . The phospholipidic composition according to one of claims 5 till 9, characterized in that the silicon dioxide has a particle size between 5 nm and 25 nm, preferably between 10 nm and 20 nm.
11 . The phospholipidic composition according to one of claims 5 till 10 , characterized in that the silicon dioxide has a surface area between 100 m 2 /g and 300 m 2 /g, preferably between 150 m 2 /g and 250 m 2 /g.
12 . The phospholipidic composition according to one of the preceding claims, characterized in that the composition contains at least one calcium salt of phosphoric acid as a granulation aid.
13 . The phospholipidic composition according to claim 12 , characterized in that the calcium salt of phosphoric acid is tricalcium phosphate.
14 . The phospholipidic composition according to one of the preceding claims, characterized in that the tricalcium phosphate contains less than 10% by weight monocalcium phosphate and/or less than 10% by weight dicalcium phosphate, each based on the total amount of said tricalcium phosphate.
15 . The phospholipidic composition according to one of the preceding claims, characterized in that the composition is free of usual binders.
16 . The phospholipidic composition according to one of the preceding claims, characterized in that the concentration of L-α-glycerophosphatidylcholine in the composition is greater than 70% by weight.
17 . The phospholipidic composition according to claim 16 , characterized in that the concentration of L-α-glycerophosphatidylcholine in the composition is between 80% by weight and 95% by weight.
18 . The phospholipidic composition according to one of claims 1 till 16 , characterized in that the composition contains
10 to 80% by weight L-α-glycerophosphatidylcholine
0 to 40% by weight cellulose
0.5 to 50% by weight calcium monophosphate, calcium diphosphate and/or calcium triphosphate, and
0.5 to 3% by weight silicon dioxide.
19 . The phospholipidic composition according to claim 18 , characterized in that the composition contains
40 to 70% by weight L-α-glycerophosphatidylcholine 10 to 30% by weight cellulose 10 to 30% by weight calcium monophosphate, calcium disphosphate and/or calcium triphosphate, and 1.5 to 2.5% by weight silicon dioxide.
20 . The phospholipidic composition according to one of the preceding claims, characterized in that the L-α-glycerophosphatidylcholine is of vegetable origin and is isolated from soybeans in particular.
21 . The use of the phospholipidic composition according to one of claims 1 till 20 in food products, cosmetics or pharmaceutical products.Join the waitlist — get patent alerts
Track US2003206881A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.